Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | MPO | P05164 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | TACR1 | P25103 | 2/20 | 0.50 |
| ▸ | PTPRA | P18433 | 1/20 | 0.46 |
| ▸ | CDK2 | P24941 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9540559 | 0.82 | TACR1 (0.61) | KMT2ALMNAKDM4EMEN1MAPT | |
| Ammonia Solution, Strong SCHEMBL5385746 | 0.81 | KMT2A (0.52) | KMT2ALMNAKDM4EMEN1MAPT | |
| SCHEMBL27744048 | 0.80 | KMT2A (0.54) | KMT2ALMNAKDM4EMEN1MAPT | |
| SCHEMBL5970060 | 0.80 | FAAH (0.61) | KMT2ALMNAKDM4EMEN1MAPT | |
| SCHEMBL5970050 | 0.80 | FAAH (0.61) | KMT2ALMNAKDM4EMEN1MAPT | |
| SCHEMBL1981757 | 0.80 | MAPT (0.68) | KMT2ALMNAKDM4EMEN1MAPT | |
| SCHEMBL8740387 | 0.80 | KMT2A (0.53) | KMT2ALMNAKDM4EMEN1MAPT | |
| SCHEMBL18000223 | 0.79 | MAPT (0.64) | KMT2ALMNAKDM4EMEN1MAPT | |
| SCHEMBL17859728 | 0.78 | KMT2A (0.62) | KMT2ALMNAKDM4EMEN1MAPT | |
| SCHEMBL1653001 | 0.78 | GPR35 (0.43) | KMT2AKDM4EMEN1TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110092557-A1 | Neuraminidase Inhibitors And Compositions And Methods Related Thereto | INFLUMEDIX INC. (US) | 2011-04-21 | — | — | US | claimed |
| US-20110092557-A1 | Neuraminidase Inhibitors And Compositions And Methods Related Thereto | INFLUMEDIX INC. (US) | 2011-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110092557-A1 | Neuraminidase Inhibitors And Compositions And Methods Related Thereto | NEU1, DAO, NEU3 | KMT2A 1624/4885LMNA 1830/4885KDM4E 2909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.